Eiger Biopharmaceuticals Inc buy melinda
Start price
12.10.17
/
50%
€12.36
Target price
11.01.18
€13.53
Performance (%)
9.49%
End price
11.01.18
€13.53
Summary
This prediction ended on 11.01.18 with a price of €13.53. With a performance of 9.49%, the BUY prediction by melinda for Eiger Biopharmaceuticals Inc closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Eiger Biopharmaceuticals Inc | - | - | - | - |
| iShares Core DAX® | -0.922% | -1.993% | 13.399% | 16.075% |
| iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% | 46.938% |
| iShares Nikkei 225® | 2.224% | -5.187% | 20.497% | 4.643% |
| iShares S&P 500 | -0.026% | -0.918% | 30.410% | 42.418% |
Comments by melinda for this prediction
In the thread Eiger Biopharmaceuticals Inc diskutieren
orphan Krankheiten wie Sarasar, pegyliertem Interferon Lambda, Exendin 9-39 und Ubenimex.
Noted 24. Juli 2017 , dass die Registrierung abgeschlossen ist. Vorläufige Daten fällig AASLD vom 20. bis 24. Oktober 2017.
Stopped prediction by melinda for Eiger Biopharmaceuticals Inc
Eiger Biopharmaceuticals Inc
Start price
Target price
Perf. (%)
€2.50
10.02.23
10.02.23
€4.00
10.02.24
10.02.24
-58.40%
31.05.23
31.05.23
Eiger Biopharmaceuticals Inc
Start price
Target price
Perf. (%)
€5.30
13.03.20
13.03.20
€9.00
04.11.21
04.11.21
28.02%
05.11.21
05.11.21
Eiger Biopharmaceuticals Inc
Start price
Target price
Perf. (%)
€13.30
02.04.19
02.04.19
€14.43
13.03.20
13.03.20
-60.16%
13.03.20
13.03.20
Eiger Biopharmaceuticals Inc
Start price
Target price
Perf. (%)
€9.22
15.10.18
15.10.18
€10.28
17.10.18
17.10.18
13.75%
17.10.18
17.10.18
Eiger Biopharmaceuticals Inc
Start price
Target price
Perf. (%)
€8.16
07.04.17
07.04.17
€9.92
15.09.17
15.09.17
23.20%
15.09.17
15.09.17